LIPT1
protein-codinglipoyltransferase 1
Gene summary
The process of transferring lipoic acid to proteins is a two-step process. The first step is the activation of lipoic acid by lipoate-activating enzyme to form lipoyl-AMP. For the second step, the protein encoded by this gene transfers the lipoyl moiety to apoproteins. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 13. Read-through transcription also exists between this gene and the neighboring downstream mitochondrial ribosomal protein L30 (MRPL30) gene. [provided by RefSeq, Mar 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009723
Submitter: ClinGen
The relationship between LIPT1 and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of November 23, 2020. The LIPT1 gene encodes lipoyltransferase which catalyzes the attachment of lipoate to four mitochondrial enzymes (two of which are important for energy metabolism and two of which are needed for amino acid metabolism). Defects in this process result in a disorder of lipoate biosynthesis which impacts mitochondrial energy generation and amino acid metabolism. The LIPT1 gene was first reported in relation to autosomal recessive Leigh syndrome spectrum in 2013 (PMID: 24341803). Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included four unique variants identified in two cases from two publications (PMIDs: 24341803, 29681092). No segregation data were available. Loss of function is implicated as the mechanism of disease. This gene-disease association is also supported by the biochemical function, expression, functional alteration in patient cells, rescue in human cells, and animal models (PMIDs: 27977873, 25613900, 24341803, 28803783, 31042466). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on November 23, 2020 (SOP Version 7).
Inheritance Pattern: AR
Disease ID:MONDO:0014576
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0014576
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014576
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014576
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014576
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014576
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to LIPT1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_145199.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 20 | 1 | 21 | |||
| missense | 1 | 5 | 70 | 3 | 1 | 80 |
| nonsense | 3 | 2 | 5 | |||
| start loss | 1 | 1 | 2 | |||
| frameshift | 4 | 3 | 7 | |||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 1 | 13 | 75 | 24 | 2 | 115 |
Highest pathogenic variant AF is 0.0009130365
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_660200.1 | 1 | MANE Select | |
| Ensembl | ENSP00000498546.1 | 1 | MANE Select | |
| RefSeq | NP_001191759.1 | 1 | Standard | |
| RefSeq | NP_057013.1 | 1 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Lipoic acid metabolism - Homo sapiens (human)
- Metabolism of amino acids and derivatives
- Metabolism
- lipoate salvage
- Glyoxylate metabolism and glycine degradation
Biological Process
- cellular protein modification process
- lipid metabolic process
- protein lipoylation
- cellular nitrogen compound metabolic process
Molecular Function
- transferase activity, transferring acyl groups
Cellular Component
- mitochondrion
- mitochondrial matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000393477
- Coding exons
- 1
- Length
- 8203
- Individuals with no LoFs
- 125468
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 274
- Defined
- 125742
- p
- 0.00109
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.340 | 178 | 191 | 0.931 | 0.00000895 | 2480 |
| Missense (PolyPhen) | 52 | 60.578 | 0.85839 | 772 | ||
| Synonymous | 0.582 | 62 | 68.1 | 0.910 | 0.00000312 | 700 |
| Loss of Function | -0.196 | 11 | 10.3 | 1.07 | 4.30e-7 | 151 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00037 | 0.00037 | rare |
| Latino/Admixed American | 0.00026 | 0.00026 | rare |
| Ashkenazi Jewish | 0.0028 | 0.0028 | notable |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.0019 | 0.0019 | notable |
| South Asian | 0.00030 | 0.00029 | rare |
| Other | 0.00049 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes the transfer of the lipoyl group from lipoyl- AMP to the specific lysine residue of lipoyl domains of lipoate- dependent enzymes. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.182
Intolerance Scores
- LoFtool
- 0.143
- RVIS EVS
- -0.27
- RVIS percentile EVS
- 34.32
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.00158
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |